Early Detection of Lung Cancer with Meso Tetra (4-Carboxyphenyl) Porphyrin-Labeled Sputum

Journal of Thoracic Oncology

Volumn 10, Issue 9, 2015, Pages 1311-1318

  Patriquin, Lara ^a   Merrick, Daniel T ^b   Hill, David ^c   Holcomb, Richard G ^d   Lemieux, Madeleine E ^e   Bennett, Gordon ^f   Karia, Bijal ^f   Rebel, Vivienne I ^g   Bauer, Thomas ^h  

^a RAA   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c WPA   (United States)

^d IQVIA   (United States)

^e Bioinfo   (Canada)

^f BioAffinity Technologies   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Early detection; Lung cancer; Porphyrin; Sputum cytology

Indexed keywords

PORPHYRIN DERIVATIVE; TETRA (4 CARBOXYPHENYL) PORPHYRIN; UNCLASSIFIED DRUG; PORPHYRIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL SIZING (MEASUREMENT); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX RATIO; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM CYTODIAGNOSIS; CYTOLOGY; EARLY CANCER DIAGNOSIS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PROCEDURES; SPUTUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PORPHYRINS; SPUTUM; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84940109289     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000627     Document Type: Article

References (24)

1. Howlader N, Noone AM, Krapcho M, SEER Cancer Statistics Review, 1975-2011 Bethesda, MD National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2011 (based on November 2013 SEER data submission, posted to the SEER web site, April 2014. Available at: http://seer.cancer.gov/statfacts/html/lungb.html). Accessed June 2014.
2. Goldberg SW, Mulshine JL, Hagstrom D, Pyenson BS, An actuarial approach to comparing early stage and late stage lung cancer mortality and survival. Popul Health Manag 2010 13 33 46
3. Aberle DR, Adams AM, Berg CD, Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011 365 395 409
4. Church TR, Black WC, Aberle DR, Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013 368 1980 1991
5. Moyer VA, U.S. Preventive Services Task Force Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014 160 330 338
6. Neumann T, Meyer M, Patten FW, Premalignant and malignant cells in sputum from lung cancer patients. Cancer 2009 117 473 481
7. Li G, Guillaud M, LeRiche J, Automated sputum cytometry for detection of intraepithelial neoplasias in the lung. Anal Cell Pathol (Amst) 2012 35 187 201
8. Figge FH, Weiland GS, Manganiello LO, Cancer detection and therapy; affinity of neoplastic, embryonic, and traumatized tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 1948 68 640
9. Campanella R, Membrane lipids modifications in human gliomas of different degree of malignancy. J Neurosurg Sci 1992 36 11 25
10. Gal D, MacDonald PC, Porter JC, Simpson ER, Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int J Cancer 1981 28 315 319
11. Galeotti T, Borrello S, Minotti G, Masotti L, Membrane alterations in cancer cells: the role of oxy radicals. Ann N Y Acad Sci 1986 488 468 480
12. Galeotti T, Borrello S, Palombini G, Lipid peroxidation and fluidity of plasma membranes from rat liver and Morris hepatoma 3924A. FEBS Lett 1984 169 169 173
13. Osterloh J, Vicente MGH, Mechanisms of porphyrinoid localization in tumors. J Porphyrins Phthalocyaniones 2002 6 305 324
14. Vitols S, Peterson C, Larsson O, Holm P, Aberg B, Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res 1992 52 6244 6247
15. Bonneau S, Vever-Bizet C, Morlière P, Mazière JC, Brault D, Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. Biophys J 2002 83 3470 3481
16. Morlière P, Momenteau M, Candide C, Synthesis, cellular uptake of, and cell photosensitization by a porphyrin bearing a quinoline group. J Photochem Photobiol B 1990 5 49 67
17. Lipson RL, Baldes EJ, Olsen AM, Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg 1961 42 623 629
18. Rasmussen-Taxdal DS, Ward GE, Figge FH, Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Surg Forum 1955 5 619 624
19. Lavi A, Weitman H, Holmes RT, Smith KM, Ehrenberg B, The depth of porphyrin in a membrane and the membrane's physical properties affect the photosensitizing efficiency. Biophys J 2002 82 2101 2110
20. Ricchelli F, Jori G, Gobbo S, Tronchin M, Liposomes as models to study the distribution of porphyrins in cell membranes. Biochim Biophys Acta 1991 1065 42 48
21. Henschke CI, International early lung cancer action program: enrollment and screening protocol. 1 July 2011. Available at: http://ielcap.org/sites/default/files/ielcap.pdf
22. Greenberg SD, Recent advances in pulmonary cytopathology. Hum Pathol 1983 14 901 912
23. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D, Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994 54 1634 1637
24. Tammemagi MC, Lam S, Screening for lung cancer using low dose computed tomography. BMJ 2014 348 g2253